Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Colby Young

Orthopaedic Surgery Las Vegas, NV Medical Doctor

NPI 1447270178 CMS profile 19883

9321 W Sunset Rd, Las Vegas, NV 89148

Open in the dashboard

General payments

$26,872

78 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$80,933 paid to institutions, not to them · program years 2019–2023

Through program year 2024, Colby Young of Las Vegas, NV is reported in the CMS Open Payments database as having received $26,872 across 78 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $80,933 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 83rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $309 11
2023 General $410 7
2022 General $11,158 10
2021 General $7,603 7
2020 General $3,949 21
2019 General $3,444 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Colby Young
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Colby Young were reported at $0. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Colby Young Orthopaedic Surgery median Middle half National median
2019 $3,444 $644 $140–$2,844 $163
2020 $3,949 $312 $75–$1,860 $114
2021 $7,603 $520 $117–$2,495 $132
2022 $11,158 $598 $128–$2,731 $149
2023 $410 $461 $128–$2,264 $160
2024 $309 $497 $134–$2,475 $164
2025 $0 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Skeletal Dynamics Inc $17,433 9 payments
  2. Goode Surgical Inc $5,156 20 payments
  3. Arthrex, Inc. $3,177 17 payments
  4. Smith+Nephew, Inc. $440 14 payments
  5. Stryker Corporation $193 2 payments
  6. AxoGen $118 2 payments
  7. Endo Pharmaceuticals Inc. $105 2 payments
  8. Zimmer Biomet Holdings, Inc. $91 3 payments
  9. Zimvie Inc. $46 2 payments
  10. Orthofix Medical, Inc. $41 3 payments
  11. Other $72 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Education $15,234 8 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,200 1 payment
  3. Food and Beverage $2,621 58 payments
  4. Travel and Lodging $1,817 11 payments
Products named General payments · program years 2019–2024
  1. Geminus $17,433 9 payments
  2. Align $17,433 9 payments
  3. IJS $17,433 9 payments
  4. IMPlate $17,433 9 payments
  5. Q-FIX $136 4 payments
  6. DISTAL EXTREMITIES IMPLANTS ANCHORS LIGAMENT AUGMENTATION $122 1 payment
  7. ENDOBUTTON $121 3 payments
  8. AxoGuard Nerve Connector $118 2 payments
  9. AXOGUARD NERVE PROTECTOR $118 2 payments
  10. VARIAX $115 1 payment
  11. Other $795 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$32,922

Of which drugs: $238

Medicare patients

73

Average age 72

Services billed

2,165

46 women, 27 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 71%
Ischemic heart disease 37%
Diabetes 33%
Chronic kidney disease 26%
Depression 25%
COPD 16%
Osteoporosis 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 25 46 $232

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

78 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record